嘧啶拼接3-烯键氧化吲哚衍生物的合成及其抗肿瘤活性

以2-吲哚酮与3,5-二氯嘧啶甲醛为原料,经Knoevenagel加成消除反应和取代反应合成了11个新型的嘧啶拼接3-烯键氧化吲哚衍生物(3a~3k),产率70%~91%,Z/E值15：1~>20 ：1, 其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。采用MTT法研究了3a~3k对人肺癌细胞(A549)和人白血病细胞(K562)的体外抗肿瘤活性。结果表明：3a, 3c, 3f, 3g和3j对K562具有较好的抑制活性（IC₅₀分别为29.3, 27.6, 28.5, 24.0和27.0 μmol·L^-1）, 3a, 3h和3j对A549具有较好的抑制活性（IC₅₀分别为28.1, 16.4和25.2 μmol·L^-1）。     

Neobavaisoflavone May Modulate the Activity of Topoisomerase Inhibitors towards U-87 MG Cells: An In Vitro Study

Despite many advances in therapy, glioblastoma (GB) is still characterized by its poor prognosis. The main reason for this is unsuccessful treatment, which slightly extends the duration of remission; thus, new regimens are needed. One of many types of chemotherapeutics that are being investigated in this field is topoisomerase inhibitors, mainly in combination therapy with other drugs. On the other hand, the search for new anti-cancer substances continues. Neobavaisoflavone (NBIF) is a natural compound isolated from Psoralea corylifolia L., which possesses anti-oxidant, anti-inflammatory, and anti-cancer properties. The aim of this study was to evaluate the effect of NBIF in human U-87 MG glioblastoma cells in comparison to normal human NHA astrocytes, and to examine if it influences the activity of irinotecan, etoposide, and doxorubicin in this in vitro model. We demonstrated that NBIF decreases U-87 MG cells viability in a dose-dependent manner. Furthermore, we found that it inhibits cell growth and causes glutathione (GSH) depletion more intensely in U-87 MG cells than in astrocytes. This study also provides, for the first time, evidence of the potentialization of the doxorubicin effect by NBIF, which was shown by the reduction in the viability in U-87 MG cells.     

Cytotoxic Naphtho‐γ‐pyrones from the Mangrove Endophytic Fungus Aspergillus tubingensis (GX1‐5E)

Four new dimeric naphtho‐γ‐pyrones, named rubasperone D ( 1 ), rubasperone E ( 2 ), rubasperone F ( 3 ), and its atropisomer rubasperone G ( 4 ), together with four known monomeric naphtho‐γ‐pyrones, TMC 256 A1 ( 5 ), rubrofusarin B ( 6 ), fonsecin ( 7 ), and flavasperone ( 8 ), were isolated from the mangrove endophytic fungus Aspergillus tubingensis (GX1‐5E) cultivated in solid rice medium. Their structures were elucidated by spectroscopic methods, including IR, 1D‐ and 2D‐NMR, and MS. In the in vitro cytotoxicity assays, 5 displayed inhibitory activities against tumor cell lines of MCF‐7, MDA‐MB‐435, Hep3B, Huh7, SNB19, and U87 MG with IC₅₀ values between 19.92 and 47.98 μM . Compounds 1, 6 , and 8 also showed mild cytotoxic activity.     

孔雀石绿单克隆抗体制备和酶联免疫检测方法的建立

针对孔雀石绿三苯环特征结构,设计合成1种高质量半抗原。通过偶联载体蛋白、动物免疫和细胞融合,制备出一株高质量的单克隆抗体MG-DA4-C7,亚类为IgG1,轻链为κ型。通过对包被原浓度、抗体浓度、二抗浓度的优化,建立了孔雀石绿间接竞争酶联免疫分析方法。方法半抑制浓度( IC50)为0.96μg/L,线性检测范围(IC20~C80)为0.1~8.1μg/L,LOD(IC10)为0.05μg/L,回归方程y=-0.3274lgx+0.4698(R2=0.9891)。本方法特异性高,与代谢物隐孔雀石绿交叉反应小于0.1％,与结晶紫、灿烂绿交叉反应率分别为18.1％和26.5％;实际样品添加回收率为87.3％~107.3％。本方法测定结果经HPLC-MS/MS方法确证,二者相关系数达0.999。本方法可用于鱼类等水产品中孔雀石绿残留的实际检测。     

Design,Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as Potential Antitumor Agents

A series of novel 4-phenoxyquinoline derivatives containing 3-amino-2-cyano-acrylamide framework was designed and synthesized, and the in vitro cytotoxic activities of them against five cancer cell lines(HT-29, H460, A549, MKN-45, and U87MG) were evaluated. Most of the compounds exhibited moderate-to-significant cytotoxicity and high selectivity against one or more cell lines as compared with Foretinib. The studies of their preliminary structure-activity relationships(SARs) indicate that the compounds containing methyl groups, especially methyl groups at 4-position of the phenyl ring(moiety B) are more effective. Among them, compound 36 shows the most potent antitumor activities with IC₅₀ values of 0.04, 0.09, 0.67, 0.39 and 1.10 μmol/L against HT-29, H460, A549, MKN-45 and U87MG cell lines, respectively.     

Die Perthioborate RbBS3, TIBS3 und TI3B3S10

The Perthioborates RbBS₃, TIBS₃, and Tl₃B₃S₁₀ . RbBS₃ (P2₁/c, a=7.082(2) Å, b=11.863(4) Å, c=5.794(2) Å, β=106.54(2)°) was prepared as colourless, plate-shaped crystals by reaction of stoichiometric amounts of rubidium sulfide, boron, and sulfur at 600°C and subsequent annealing. TlBS₃ (P2₁/c, a=6.874(3) Å, b=11.739(3) Å, c=5.775(2) Å, β=113.08(2)°) which is isotypic with RbBS₃ was synthesized from a sample of the composition Tl₂S · 2 B₂S₃. The glassy product which was obtained after 7 h at 850°C was annealed in a two zone furnace for 400 h at 400→350°C. Yellow crystals of TlBS₃ formed at the warmer side of the furnace. Tl₃B₃S₁₀ (P1 , a=6.828(2) Å, b=7.713(2) Å, c=13.769(5) Å, α=104.32(2)°, β=94.03(3)°, γ=94.69(2)°) was prepared as yellow plates from stoichiometric amounts of thallium sulfide, boron, and sulfur at 850°C and subsequent annealing. All compounds contain tetrahedrally coordinated boron. The crystal structures consist of polymeric anion chains. In the case of RbBS₃ and TlBS₃ nonplanar five-membered B₂S₃ rings are spirocyclically connected via the boron atoms. To obtain the anionic structure of Tl₃B₃S₁₀ every third B₂S₃ ring of the polymeric chains of MBS₃ is to be substituted by a six-membered B(S₂)₂B ring.     

The redox couple avarol/avarone in the fight with malignant gliomas: the case study of U-251 MG cells

This study aimed to screen in vitro antitumour activity of the redox couple avarol/avarone against the human malignant glioma cell line U-251 MG for the first time. Compared both with avarol and positive controls used (temozolomide and doxorubicin), avarone was found to be the most active compound with IC₅₀ value below 1 μM (IC₅₀ 0.68 ± 0.04 μM, 96 h). Considerable less DNA damage in the cells treated with avarol and avarone vs. doxorubicin (105 & 123% vs. 299%, respectively; untreated U-251 MG cells were used as a control, 100%), coupled with no sign of cytotoxicity against the normal human foetal lung fibroblast MRC-5 cells (IC₅₀ > 100 μM), has actually pointed out the importance of this marine sesquiterpenoid quinone structure as a promising lead compound in development of novel brain chemotherapeutics.     

5-(4-氟苯基)-N-1-(3-羟基金刚烷基)-7-三氟甲基吡唑并[1,5-a]嘧啶-3-酰胺的合成及其抗肿瘤活性

以乙氧基甲叉基氰乙酸乙酯和对氟苯乙酮为起始原料,设计并合成了新化合物5-(4-氟苯基)-N-1-(3-羟基金刚烷基)-7-三氟甲基吡唑并[1,5-a]嘧啶-3-酰胺(7),其结构经~1H NMR,IR和HR-MS(ESI)表征。采用MTT法测定了其对人乳腺癌细胞(Bcap-37)、人宫颈癌细胞(He La229)、人肝癌细胞(QGY-7701)和人肺癌细胞(A549)体外抗肿瘤细胞的增殖活性。结果表明:7对受试细胞的抑制活性较好,其IC_(50)值分别为23.9μmol·L~(-1),29.8μmol·L~(-1),31.4μmol·L~(-1)和21.7μmol·L~(-1)。     

Synthesis,Enzyme Inhibition,and Molecular Docking Studies of Hydrazones from Dichlorophenylacetic Acids

A series of hydrazones 5a–i were synthesized by the condensation of hydrazides derived from dichlorophenylacetic acids with different aromatic aldehydes and ketones. Their structures were confirmed by spectroscopic data and elemental analysis. Hydrazones 5a–i were evaluated for α‐glucosidase and urease inhibition activities. Five compounds exhibited potent α‐glucosidase inhibitory potential with IC₅₀ values 8.5 ± 0.3, 22.2 ± 0.78, 32.9 ± 1.5, 34 ± 2.4, and 170.6 ± 7.5 μM, respectively, which are many times better than that of the standard inhibitor acarbose (IC₅₀ = 840 ± 1.73 μM). Furthermore, molecular docking study was performed to explore the binding mode in the active sites of α‐glucosidase and urease enzymes.     

Syntheses and Crystal Structures of Ca3Fe2(SeO3)6 and Sr3Fe2(SeO3)6

The new compounds M₃Fe₂(SeO₃)₆ (M = Ca, Sr) were obtained as crystalline precipitates from aqueous solutions of the respective ions, kept in Teflon-coated vessels at a temperature of 227(2)°C for several days. The crystal data are: space group R3 c, a = 8.531(2), 8.802(2) Å; c = 38.89(1), 39.00(1) Å; V = 2451.1, 2616.7 ų, Z = 6. The crystal structures have been refined by single-crystal X-ray diffraction methods to R1 = 0.021, 0.023; wR2 = 0.038, 0.039. The framework structure is built up by two types of FeO₆ octahedra as well as by MO₈ groups and SeO₃ trigonal pyramids by corner- and edge-linkage of the polyhedra.     

The Crystal Structure of Tl2Te3 – a Reinvestigation

Crystals of the title compound were obtained by annealing a powder of Tl₂Te₃ in a vertical temperature gradient (230 °C–240 °C, 4 weeks). Tl₂Te₃ crystallizes in space group C2/c with lattice parameters of a = 13.275(1) Å, b = 6.562(1) Å, c = 7.918(1) Å, and β = 107.14°(2). The tellurium atoms form chains [Te₃^2–], consisting of interconnected linear triatomic · Te–^Te–Te · groups which are isosteric with XeF₂. The Te–Te distances of the XeF₂-like units are 3.02 Å, the connecting ones 2.83 Å.     

Zintl‐Verbindungen mit Gold und Germanium: M3AuGe4 mit M = K,Rb und Cs

Zintl‐Compounds with Gold and Germanium: M₃AuGe₄ with M = K, Rb, Cs Black, brittle single crystals of M₃AuGe₄ with M = K, Rb, Cs were synthesized by reactions of alkali metal azides (MN₃) with gold sponge and germanium powder at T = 1120 K. The structures of the compounds (space group Pmmn, Z = 2, K₃AuGe₄: a = 6.655(1)Å, b = 11.911(2)Å, c = 6.081(1)Å; Rb₃AuGe₄: a = 6.894(1)Å, b = 12.421(1)Å, c = 6.107(1)Å; Cs₃AuGe₄: a = 7.179(1)Å, b = 12.993(2)Å, c = 6.112(2)Å) were determined from X‐ray single‐crystal diffractometry data. The semiconducting compounds contain equation/tex2gif-stack-2.gif[AuGe₄]‐chains with P₄‐analogous Ge₄‐tetrahedra which are connected by μ₂‐bridging gold atoms in a distorted tetrahedral Ge‐coordination.     

3-Hydroxymethylglutaryl flavonol glycosides from a Mongolian and Tibetan medicine, Oxytropis racemosa

Three new flavonol 3-O-glycosides, rhamnetin 3-O-[(S)-3-hydroxy-3-methyl-glutaroyl(1→6)]-β-D-glucopyranoside (1), rhamnocitrin 3-O-[(S)-3-hydroxy-3-methylglutaroyl(1→6)]-β-D-glucopyranoside (2), and isorhamnetin 3-O-[(S)-3-hydroxy-3-methylglutaroyl(1→6)]-α-L-rhamnopyranosyl(1→2)-β-D-glucopyranoside (3), along with 13 known compounds, were isolated from Oxytropis racemosa TURCZ. Their structures were deduced by means of spectroscopic methods and chemical evidence. 2 and 6 showed cytotoxic activities against HCT-8 (IC?? 6.38 μM) and A549 (IC?? 5.20 μM), respectively.     

Network pharmacology-based approach of novel traditional Chinese medicine formula for treatment of acute skin inflammation in silico

Matrix metalloproteinase-9 (MMP-9) appears to play an important role in acute skin inflammation. Subantimicrobial dose of tetracycline has been demonstrated to inhibit the activity of MMP-9 protein. However, long-term use tetracycline will induce side effect. The catalytic site of MMP-9 is located at zinc-binding amino acids, His401, His405 and His411. We attempted to search novel medicine formula as MMP-9 inhibitors from traditional Chinese medicine (TCM) database by using in silico studies. We utilized high-throughput virtual screening to find which natural compounds could bind to the zinc-binding site. The quantitative structure-activity relationship (QSAR) models, which constructed by scaffold of MMP-9 inhibitors and its activities, were employed to predict the bio-activity of the natural compounds for MMP-9. The results showed that Celacinnine, Lobelanidine and Celallocinnine were qualified to interact with zinc-binding site and displayed well predictive activity. We found that celallocinnine was the best TCM compound for zinc binging sites of MMP-9 because the stable interactions were observed under dynamic condition. In addition, Celacinnine and Lobelanidine could interact with MMP-9 related protein that identified by drug-target interaction network analysis. Thus, we suggested the herbs Hypericum patulum, Sedum acre, and Tripterygium wilfordii that containing Celallocinnine, Celacinnine and Lobelanidine might be a novel medicine formula to avoid the side effect of tetracycline and increase the efficacy of treatment.     

新型吡啶类c-Met激酶抑制剂的设计、合成及抗肿瘤活性

以BMS-777607和E7050为先导化合物,设计并合成了11个新型的吡啶类c-Met激酶抑制剂（9a~9f和10a~10e）,其结构经¹H NMR和MS(ESI)表征。采用MTT法测定了9a~9f和10a~10e对人胃癌细胞株(NCI-N87和GTL-16)的体外抗肿瘤细胞增殖活性。结果表明：9a, 9d和10a对GTL-16的抑制活性较好,其IC₅₀分别为0.60 μmol·L^-1, 1.36 μmol·L^-1和0.93 μmol·L^-1,优于BMS-777607（2.50 μmol·L^-1）。     

Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach

In an attempt to develop potent and selective anti-tumor agents, two novel series of artemisinin-chalcone hybrids were designed, synthesized and screened for their antitumor activities against HT-29, A549, MDA-MB-231, HeLa and H460 cell lines in vitro. Nearly all of the tested compounds showed significantly increased anti-tumor activity compared with the corresponding dihydroartemisinin (DHA). Most of the title compounds displayed good selectivity toward HT-29 and HeLa cell lines with IC?? values ranging from 0.09 to 0.85 μM. Among them, the most promising compound 9c (IC??) range of 0.09-0.93 μM) was 10.5- to 70-times more active than DHA (IC?? range of 5.6-15.6 μM) respectively.     

Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state

The synthesis and the structure-activity relationships of renin inhibitors designed from the angiotensinogen transition state are described. These inhibitors contained residues modified at P1-P1', P2, and P4-P3. Decrease in the size of side chain alkyl group in norstatine analog at P1 diminished the inhibitory activities of the compounds. Compound 5j, which contained valine residue instead of histidine residue at P2, inhibited potently cathepsin D (IC50 = 6.0 x 10(-9) M) and pepsin (IC50 = 3.5 x 10(-7) M) to the same extent as renin (IC50 = 8.5 x 10(-10) M), and thus was not specific for renin. The reduction of the beta-carbonyl group to methylene group in beta-carbonylpropionyl residue at P4-P3 decreased the potency about 2 orders against human renin (5i: IC50 = 1.1 x 10(-7) M vs. 1: IC50 = 2.4 x 10(-9) M). These results confirmed the rationality of our analysis of the interaction between an orally potent human renin inhibitor 1 and the active site of human renin using modeling techniques, showing that 1 fits the active site of renin favorably. The experimental details of the synthesis are presented.     

Tebrophen--an old polyphenol drug with anticancer potential

In vitro high-throughput screening was carried out in order to detect new activities for old drugs and to select compounds for the drug development process comprising new indications. Tebrophen, a known antiviral drug, was found to inhibit activities on inflammation and cancer related targets. In primary screening this semisynthetic halogenated polyphenol was identified to inhibit the activities of kinases ZAP-70 and Lck (IC?? 0.34 μM and 16 μM, respectively), as well as hydrolase DPPIV (at 80 μM 41% inhibition). Next, it showed no cytotoxic effects on standard cell lines within 24 h. However, tebrophen slowed propagation of breast cancer (MDA-MB-231), osteosarcoma (U2OS) and cervical carcinoma (HeLa), through at least 35 population doublings in a dose-dependent manner. It completely stopped the division of the prostate cancer (PC3) cell line at 50 μM concentration and the cells entered massive cell death in less than 20 days. On the other hand, tebrophen did not influence the growth of normal fibroblasts. According to the measured oxidative burst and estimated in silico parameters its direct antioxidative ability is limited. The obtained results indicate that tebrophen can be considered a promising lead molecule for generating more soluble derivatives with specific anticancer efficacy.